The North America asthma therapeutics market benefits from the use of combination inhalers containing corticosteroids and long-acting bronchodilators. These treatments play an important role in maintenance care, while biologic medicines provide additional options for eligible patients with severe asthma.
The asthma therapeutics market is projected to reach US$ 37.86 billion by 2031, registering...
Portuguese
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek